Lepu Medical Technology (Beijing) Co., Ltd. (SHE:300003)
China · Delayed Price · Currency is CNY 12.29
+0.27 (2.25%)
Oct 23, 2026, 3:04 PM CST
SHE:300003 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 6,171 | 6,483 | 6,103 | 7,980 | 10,609 | 10,660 |
Revenue Growth | -1.37% | 6.22% | -23.52% | -24.79% | -0.47% | 32.61% |
Gross Profit Gross Profit Growth | 3,641 | 4,038 | 3,547 | 4,998 | 6,588 | 6,494 |
Operating Income Operating Income Growth | 738.57 | 1,259 | 427.99 | 1,594 | 2,795 | 2,612 |
Net Income Net Income Growth | 658.24 | 962.01 | 246.94 | 1,258 | 2,204 | 1,719 |
Earnings Per Share EPS Growth | 0.36 | 0.52 | 0.13 | 0.68 | 1.21 | 0.95 |
EPS Growth | 54.45% | 290.64% | -80.23% | -44.29% | 27.54% | -6.22% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Medical Instruments Medical Instruments Growth | 3,254 | 3,326 | 3,674 | 5,879 | 6,169 |
Pharmaceutical Pharmaceutical Growth | 2,165 | 1,758 | 3,044 | 3,438 | 3,258 |
Medical Services and Health Management Medical Services and Health Management Growth | 1,063 | 1,019 | 1,262 | 1,293 | 1,232 |
Total Total Growth | 6,483 | 6,103 | 7,980 | 10,609 | 10,660 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 4,056 | 4,633 | 3,993 | 4,496 | 5,744 | 3,798 |
Total Debt Total Debt Growth | 4,718 | 6,388 | 5,770 | 4,911 | 4,342 | 4,842 |
Net Cash (Debt) Net Cash Growth | -662 | -1,755 | -1,777 | -414.79 | 1,403 | -1,044 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.36 | -0.95 | -0.96 | -0.22 | 0.77 | -0.58 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1,358 | 1,517 | 734.64 | 990.36 | 2,791 | 3,062 |
Capital Expenditures CapEx Growth | -882.19 | -643.06 | -658.82 | -844.67 | -905.22 | -984.4 |
Free Cash Flow Free Cash Flow Growth | 476.15 | 873.86 | 75.82 | 145.69 | 1,885 | 2,078 |
Free Cash Flow Growth | -33.73% | 1052.51% | -47.96% | -92.27% | -9.25% | 39.48% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Gross Margin | 59.01% | 62.28% | 58.12% | 62.63% | 62.10% | 60.92% |
Operating Margin | 11.97% | 19.42% | 7.01% | 19.97% | 26.34% | 24.50% |
Pretax Margin | 11.30% | 18.76% | 3.70% | 19.48% | 24.62% | 20.13% |
Profit Margin | 10.67% | 14.84% | 4.05% | 15.77% | 20.77% | 16.13% |
FCF Margin | 7.72% | 13.48% | 1.24% | 1.83% | 17.77% | 19.49% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.326 | 0.326 | 0.277 | 0.331 | 0.341 | 0.275 |
Dividend Per Share Growth | 9.32% | 17.51% | -16.42% | -2.81% | 24.00% | 20.61% |
Dividend Yield | 2.65% | 2.06% | 2.44% | 2.05% | 1.49% | 1.21% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
PE Ratio | 29.40 | 30.30 | 84.65 | 23.92 | 19.29 | 23.59 |
Forward PE | 26.20 | 25.97 | 20.25 | 13.76 | 22.09 | 14.60 |
P/FCF Ratio | 37.32 | 33.35 | 275.70 | 206.57 | 22.54 | 19.52 |
PS Ratio | 3.50 | 4.50 | 3.43 | 3.77 | 4.01 | 3.81 |